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Clinical and biochemical criteria in the detection of renal artery 
stenosis
Peter J. Bijlstra, Cornelis T. Postma, Theo de Boo* and Theo Thien
Objective To investigate methods to diagnose renal artery 
stenosis (RAS) among the general hypertensive population.
Methods We studied the value of clinical and biochemical 
characteristics at the outpatient clinic to identify subjects 
with a renal artery narrowing of more than 50% of the 
luminal surface among 1047 hypertensive patients. In­
cluded in the analysis were: blood pressure, age, sex, body 
mass index, endogeneous creatinine clearance, smoking 
and plasma renin activity.
Resuits Among the 1047 patients, 355 were selected for 
angiography. In this subgroup 104 patients (29°/o) had RAS. 
The subjects with RAS had significantly higher diastolic and 
systolic blood pressures than did those without stenosis. 
Forward stepwise logistical regression analysis showed 
that systolic blood pressure, stimulated plasma renin acti­
vity and smoking were the most predictive independent 
screening variables for the presence of RAS. Yet, none of 
these characteristics or their combinations were sufficiently 
sensitive to distinguish reliably between patients with 
essential hypertension and those with RAS. Sytolic 
blood pressure >160mmHg or diastolic blood pressure
Introduction
At present the only method to diagnose renal artery sten­
osis (RAS) with certainty is angiography [1,2]. The low 
prevalence of RAS among the general hypertensive 
population renders angiography, considering its cost and 
invasive nature, inappropriate as a screening procedure. 
However, the definitive treatment modalities presently 
available for this condition mandate a proper search for 
RAS among hypertensive subjects [3].
Extensive studies of alternative non-invasive methods 
have not yet provided a replacement for angiography [4-6]. 
Most of the screening methods investigated proved not 
to be sufficiently reliable because of their relatively low 
sensitivities [3].
Therefore, clinical criteria are applied to select from among 
the general hypertensive population those subjects who 
have a high likelihood of stenosis and to restrict invasive 
diagnostic interventions to these patients. By doing so, on 
the one hand the number of diagnostic interventions is 
limited and on the other hand the diagnosis of renovascular 
disease is not overlooked in too great a proportion of 
patients. Many different clinical criteria are applied in this 
selection procedure [7]. Although age, blood pressure and
>  100 mmHg on automatic (Dinamap) recording as criteria 
selected a subgroup of patients with a RAS prevalence of 
30°/o.
Conclusions By using blood pressure screening criteria a 
subgroup of hypertensive patients with a high prevalence 
of RAS can be formed in whom further invasive tests for 
RAS are indicated and efficient.
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physical characteristics such as flank bruits are generally 
accepted [7], their accuracy in this respect is not known.
With the determination of the best predictive selection 
criteria for RAS, the management of hypertensive patients 
can be improved and the size of subgroups selected for 
angiography can possibly be reduced. We studied the 
values of various clinical and biochemical criteria in this 
respect in a group of 1047 hypertensive patients of the 
outpatient clinic of our tertiary referral hospital.
Methods
Patients
From the outpatient clinic, 1047 newly referred hyper­
tensive patients were investigated by a prospectively 
designed protocol. Patients were referred by general prac- 
tioners or internists from other hospitals. The outline of 
the procedure is depicted in Figure 1. The clinical and 
biochemical characteristics studied were: age, blood pres­
sure, body mass index (BM I), sex, endogenous creatinine 
clearance (ECG ) computed by the formula of Gockroft 
[8], plasma renin activity (PRA) [9], serum potassium 
concentration [10], smoking, malignant hypertension, 
abdominal bruits, claudication of the legs, congestive heart
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Fig. 1.
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Patients with other causes of secondary hypertension were 
excluded from this study. The presence of secondary 
hypertension was investigated by determination of serum 
concentrations of electrolytes, aldosterone [12] and cate­
cholamines [13]; urine excretions of creatinine, meta- 
nephrines and protein were also determined, and urine 
microscopy was performed.
n = 79
A therosc lero tic
n = 25
Fibro-Musculnr-Dysplas ia
$CXiS»o
<3
The outline of the procedure that resulted in the three groups of patients.
failure, and a history of myocardial infarction, angina pec­
toris, cerebrovascular accident, low age at onset of hyper­
tension and resistance to therapy of the hypertension. 
Hypertension was diagnosed when mean of three con­
secutive supine sphygmomanometer diastolic blood pres­
sure readings at the outpatient clinic on three different 
visits was above 90 mmHg [11].
Grouping
In a subgroup of 355 patients arterial digital subtraction 
angiography (DSA) of the renal arteries was performed. 
The following criteria were used in the selection of these 
patients [1]: the presence of an abdominal bruit above the 
renal artery or in the flank; the onset of hypertension 
having been before the age of 20 years or after the age of 45 
years; accelerated or malignant hypertension, hypertensive 
encephalopathy or an established referral diastolic blood 
pressure (D BP) over 115 mmHg by sphygmomanometry; 
and treatment-resistant hypertension, characterized by a 
DBP over 95 mmHg despite adequate two-regimen anti­
hypertensive medication and good compliance. The results 
of the captopril test’ were not used as a selection criterion 
for angiography. The angiographies of the renal arteries 
were performed on an outpatient basis by arterial digital 
subtraction angiography and the results were studied by 
experienced radiologists. Only patients with a narrowing 
of more than 50% of the luminal surface measured by 
angiography were considered to have RAS.
By applying the above criteria a subgroup was formed in 
which a DSA was performed and the presence or absence 
of RAS thereby ascertained. Thus the value of clinical 
and biochemical criteria to discriminate between essential 
hypertension and hypertension with RAS in this subgroup
could be investigated.
Data gathering
When hypertension had been established, the first step in 
the diagnosis of all of the patients consisted of a so-called 
captopril test. This test was performed after the subjects 
had stopped both antihypertensive medication and sodium 
restriction for at least 2 weeks. The procedure was per­
formed at the outpatient clinic, during which the patients 
remained supine in a quiet room. Their blood pressure 
was recorded every 3 min by an automatic blood pressure 
device (Critikon Dinamap 1846 SX, Critikon, Tampa,
Florida, USA) throughout the procedure. Blood samples 
for creatinine and PRA determination were extracted after 
20 min of supine rest by the patient. Sixty minutes after 
the administration of an oral dose of 25 mg captopril,
samples for PRA determination were again extracted. In In order to investigate the potential role of the above­
order to standardize the blood pressure data, only the mentioned selection criteria in the detection of RAS, a 
blood pressure recordings obtained using the Dinamap separate analysis was performed in those patients who 
device were used in the analysis. The average of the three underwent arteriography. Differences between patients 
blood pressure readings just before captopril admin- with RAS based on atherosclerosis or fibromuscular dys- 
istration was taken as the baseline blood pressure. If plasia (FM D ) were also investigated.
To study the univariate relationship between the clinical 
and biochemical data and the prevalence of RAS, values 
of these parameters were grouped into classes. Within 
these classes the prevalence of RAS was determined and 
trends in the differing prevalence of RAS between these 
classes were analysed.
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Statistical analysis
The differences in die continous variables in the whole 
group of hypertensive patients were analysed by using 
Student’s t-test or Wilcoxon’s rank sum test. P<0.05 was 
considered statistically significant. All of the tests were 
two-sided. The discriminating power of the clinical and 
biochemical data in detecting the presence of RAS was 
investigated using a forwards stepwise logistical regression 
analysis. In the first analysis all of the parameters were 
included for those patients who had undergone angio­
graphy and for whom all of these data were available. In 
the second analysis claudication of the legs and abdominal 
bruits were omitted because these parameters cannot be 
used as screening parameters owing to their low frequency 
of occurrence in the hypertensive population. Differences 
between subgroups were tested using a c2-test. Values are 
expressed as means ±  SD or as medians (25-75% ranges) 
unless indicated otherwise.
Results
Patients were referred for various reasons, of which failure 
to respond to antihypertensive medication was most com­
mon. On the basis of outpatient clinic blood pressure 
measurements in 1047 Caucasian patients, a diagnosis of 
hypertension was made. In these 1047 patients a hyper­
tension work-up was performed and their data analysed. 
In 37 patients the three baseline automatic blood pressure 
readings were considered insufficiently accurate to use in 
the analysis. The reasons for this were technical problems 
with the equipment and included movement by the 
patients. For the analysis of characteristics other than 
blood pressure the data for these patients were used when 
appropriate. The eight patients with malignant hyper­
tension were treated with dihydropyridine calcium ant­
agonists during evaluation. In all of the other patients 
antihypertensive medication was discontinued for at least
2 weeks.
Whole-group characteristics
The entire group consisted of 492 male and 555 female 
patients with a mean BM I of 26.5 ±  4.7 kg/m2. The mean 
blood pressure measured using the Dinamap device was 
154 + 24/92 ± 14 mmHg. The serum creatinine con­
centration averaged 90.7 ± 38.5 mol/1 and the calculated 
EGC averaged 94.3 ±  35.6 ml/min. There were only slight 
differences in blood pressure and renal function between 
men and women (Table 1).
Differences arising from the presence of RAS
Of the 355 patients in whom angiography was performed, 
RAS was present in 104 (29%). Bilateral stenosis was 
present in 10 patients. The established prevalence of RAS 
in the entire group was therefore at least 10%.
For further analysis three different groups were formed: 
a group with RAS, a group without RAS henceforth referred 
to as essential hypertensives and a group in whom DSA
Table 1 Clinical and biochemical characteristics of 1047 
hypertensive patients
Ail patients Women Men
(n = 1047) <n = 555) (n = 492)
Age (years) 48 + 13 48 ±14 49 ± 12
Body mass index (kg/m5) 26.5 ±4.7 26.6 ± 5.6 26.3 ±3.6
Systolic blood pressure (mmHg) 154 ± 24 153 ±24 155 ± 24
Diastolic blood pressure (mmHg) 92 ± 14 90 ± 14** 93 + 14
Serum creatinine level (mol/l) 91 +39 80 ± 23** 103 ± 48
Endogenous creatinine clearance
rate (ml/min) 94 ±36 91 ±38** 98 ±32
Serum potassium level (mmol/I) 3.8 + 0.4 3.8 +0.4** 3.9 + 0.4
PRA1 (nmol/l per h) 0.9 (0.4-1.6) 0.8 (0,4-1,6) 1.0 (0.4-1.9)
PRA2 (nmol/l per h) 1.1 (0.4-2.8) 0.9 (0.4-2.3) 1.3 (0.6-3.5)
Values are expressed as means ± SD or medians (25%-75% ranges). PRA1, 
plasma renin activity at baseline; PRA2, plasma renin activity 60min after 
captopril therapy. Blood pressures were obtained by automatic blood pressure 
registration. **P<0.01, versus men.
had not been performed and the presence of RAS had not 
been determined (Fig. 1). The characteristics of the first 
two subgroups were compared and are listed in Table 2 
together with the values for the third group. SBP and 
DBP were significantly higher in the RAS group than they 
were in the essential hypertension group (Table 2). Renal 
function represented by EGC was significantly lower in 
the group with RAS than it was in the group without RAS,
The baseline PRA was significantly higher in the patients 
with RAS. Furthermore, the captopril-stimulated PRA 
reached significantly higher levels in the RAS group than 
it did in the essential hypertension group. The median 
increase in PRA was 2.7 nmol/1 per h (0.2-17.7) [median 
(25 and 75% quantiles)] in the patients with RAS and
Table 2 Clinical and biochemical characteristics of three 
subgroups of hypertensive patients (patients with renal artery 
stenosis, patients with essential hypertension and patients 
characterized as of unknown status because renal angiography 
had not been performed)
Renal artery Essential Unknown
stenosis hypertension status
Total ÎI o (n = 251) (n = 692)
Age (years) 50 ±12* 46 ±13 49 ± 13
Body mass index
(kg/m2) 24.5 ± 4.0* 26.3 ± 4,9 26.8 ± 4.7
Systolic blood pressure
(mmHg) 170 + 25* 157 + 23 151 ±23
Diastolic blood pressure
(mmHg) 100 ±14* 96 ±15 89 ± 13
Serum creatinine level
(mol/l) 107 ± 61 * 91 ±41 88 ±32
Endogenous creatinine
clearance rate (ml/min) 78 ± 29* 95 ±29 97 ±38
Serum potassium level
(m mol/l) 3.8 ± 0,4 3.8 + 0.4
PRA at baseline
(nmol/l per h) 2.0 (0.9-3.4)* 1.0 (0.4-2.0) 0.8 (0.4-1.4)
PRA after 25 mg
captopril (nmol/l per h) 4.8 (1.2-22.2)*tt 1.3 (0,4-3,9)n 1.0 (0.4-2.0)t
Values are expressed as means ± SD or medians (25%-75% quantiles). PRA, 
plasma renin activity. Blood pressures were obtained by using an automatic 
blood pressure measuring device. *P<0.05, versus essential hypertensives; 
^<0.01, versus PRA at baseline.
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Table 3 Renal artery stenosis in classes of characteristics of 1047 
hypertensive patients
Fig. 2.
Characteristic n DSA (RAS)
Age (years)
40 (7)<30 102
30-40 156 51 (8)
40-50 278 100 (33)
50-60 287 95 (30)
60-70 178 61 (23)
>70 46 8 (3)
Total 1047 355 (104)
Body mass index (kg/m2)
<20 51 22 (8)
20-22.5 139 61 (23)
22.5-25 207 81 (32)
25-27.5 240 75 (19)
27.5-30 154 44 (8)
30-35 137 38 (11)
35-40 36 14(1)
>40 16 4 (0)
Total 980 339 (102)
Diastolic blood pressure (mmHg)
<70 50 11 (1)
70-80 128 25 (5)
80-90 278 60 (1 8)
90-100 273 102 (25)
100-110 173 73 (21)
>110 91 58 (22)
Total 993 330 (92)
Systolic blood pressure (mmHg)
<120 47 10 (1)
120-140 239 58 (11)
140-160 348 116 (22)
160-180 231 83 (28)
180-200 106 48 (23)
>200 35 23 (11)
Total 1006 338 (96)
Endogenous creatinine clearance (ml/min)
<70 205 81 (38)
>70 793 261 (64)
Total 998 342 (102)
DSA, digital substraction angiography; RAS, renal artery stenosis,
0.3 nmol/l per h (0.0-1.7) in the subjects with essential 
hypertension (PcO.Ol, Table Z). Also, the relative median
increases in PRA of 140% (24-381) and 25% (0-108) in
the RAS and essential hypertension groups, respectively, 
were significantly different CP<0.01). Both baseline and 
stimulated PRA were lower in the group which had not 
undergone angiography than they were in the other groups. 
The absolute median increase in PRA in the group with 
unknown RAS status was 0.09 nmol/l per h ( — 0.03 to 0,65, 
Table 2), which is a relative change from baseline of 12%
( — 5 to 58).
Differences based on classes of characteristics
The prevalence of RAS increased with higher DBP and 
SBP (Table 3, Fig. 2). Also, in the class with a low ECC, 
the overall RAS prevalence of 19% was more than twice 
as high as that in the class with a higher ECC  (8%), The 
RAS prevalence showed a small but insignificant rise with 
increasing age (Fig. 3). Although the prevalence of RAS 
was highest in the lower BM I classes, there was no sig­
nificant inverse correlation.
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Only in the two highest classes of DBP and SBP were 
baseline and stimulated PRA significantly higher than in 
the other classes (Fig. 4). However, there was no significant 
correlation between the two variables over the entire 
spectrum of blood pressure classes (R  range 0.03-0.12),
Discrimination of predictive factors
In the initial forwards stepwise logistical regression analysis 
the following items were included: SBP, baseline PRA, 
stimulated PRA, smoking, the presence of an abdominal 
bruit, claudication, myocardial infarction, congestive heart 
failure, cerebrovascular accident, malignant hypertension 
and therapy-resistant hypertension. The results for the
Fig. 3.
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Table 4 Outcomes of different selection criteria for the detection 
of renal artery stenosis applied to 355 patients who had 
undergone angiography of whom 104 had renal artery stenosis
Criterion
Sensitivity
(%)
Specificity
(%)
Logistic regression formula 1 52 85
Logistic regression formula 2 44 84
Müller criteria [14] 30 92
DBP > 100 mmHg 44 66
SBP >160 mmHg 64 63
DBP > 100, SBP  >160 mmHg 40 77
ECC <70 ml/min 37 82
Serum potassium concentration < 3.5 mmol/l 17 86
PRA1 > 5 nmol/l per h 21 91
APRA > 2 nmol/l per h 61 74
APRA > 3 nmol/l per h 51 80
PRA1 > 2.5 nmol/ per h and ECC < 70 ml/min 23 93
PRA1 > 2.0 nmol/l per h and A%PRA > 150% 
and SBP  > 140 mmHg 34 93
PRA1 > 2,6 nmol/l per h and SBP  > 14Q mmHg 43 81
PRA1 > 2.0 nmol/l per h and A%PRA > 150% 42 90
Smoking 73 52
Claudication 29 94
Congestive heart failure 3 98
Myocardial infarction 7 94
Abdominal bruits 23 94
Cerebrovascular acccident 3 97
Malignant hypertension 2 97
Therapy resistance 61 50
Low age at onset of hypertension 6 90
DBP, diastolic blood pressure; SBP, systolic blood pressure; PRA1, baseline 
plasma renin activity; APRA, change in PRA after captopril therapy; A%PRA, 
percentage of APRA from PRA1; ECC, endogenous creatinine clearance rate.
group in which all of the patients had undergone angiog­
raphy showed that the stimulated PRA (PRA2), smok­
ing, claudication, abdominal bruits and therapy resistance 
all contributed independently to the probability of having 
RAS (P<0.05). From the logistical regression analysis, the 
intercept and coefficients with standard error and P-value 
for the remaining variables were obtained: intercept =
2.67 + 0.3 (PcO.OOl), stimulated PRA 0.0549 + 0.0125 
CP<0.001), smoking0.728 + 0.3175 CP = 0.02), claudication 
1,6557 +0.4404 (PcO.OOl), abdominal bruits 1.4779 + 
0.4629 (PcO.Ol) and therapy resistance 0.7711+0,3189 
(P = 0.02). An estimate for the probability of having RAS 
can be computed as
prob(RAS) = Z/(l + Z),
where Z = exp [ — 2.67 — 0.054 x PRA2 + 0.73 x smoking +
1.66 x claudication +1.48 x abdominal bruits+ 0.77 x therapy 
resistance].
If it is decided that RAS is present when this computed 
probability exceeds 50%, then, upon resubstitution into 
the equation of the patients who underwent angiography, 
this formula has a sensitivity of 52% and a specificity of 
85% (Table 4). The positive and negative predictive values 
are 59 and 81%, respectively.
A second forwards stepwise logistical regression analysis 
in which claudication, abdominal bruits and malignant 
hypertension were omitted, showed that SBP, stimulated
PRA (PRA2) and smoking contributed independently to 
the probability of having RAS (P < 0.05). The stimulated 
PRA had the strongest relationship with RAS (P < 0.001), 
From the logistical regression analysis, the intercept and 
coefficients with standard error and P-value for the 
remaining variables were obtained: intercept = 4.32 + 0.99
(PcO.OOl), stimulated PRA 0.0527 +0.0125 (¿><0.001), 
smoking 0.9481 +0.3016 (P<0.01) and SBP 0.0748 +
0.00597 CP = 0.01). Here Z can be computed as
Z  = exp[—4.32 -  0.053 x PRA 2 + 0.95 
x smoking + 0.01 x SBP]
If  it is decided that RAS is present when the computed 
probability exceeds 50%, then, upon resubstitution into 
the equation of the patients who underwent angiography 
this formula has a sensitivity of 44% and a specificity of 
84% (Table 4). The positive and negative predictive values 
are 53 and 78% respectively.
When the criteria of Müller [14], which are often cited in 
the literature with test results of 100% sensitivity and 
100% specificity, were applied to the same population, 
this resulted in a sensitivity of 31%, a specificity of 92%, 
a positive predictive value of 61% and a negative predictive 
value of 76% in the detection of RAS (Table 4). Table 4 
illustrates that neither PRA changes nor blood pressure 
criteria alone or in combination with other clinical data 
were of additional value in detecting RAS.
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Table 5 incidence of selection criteria for angiography in patients 
with essential hypertension versus those with renal artery 
stenosis and renal artery stenosis caused by atherosclerosis 
versus renal artery stenosis caused by fibromuscular dysplasia 
(FMD)
Renal artery stenosis
Criterion
tssentiai 
hypertension 
(n = 251)
All 
(n = 104)
Atherosclerosis 
(n = 79)
FMD 
(n = 25)
Age (years) 46 ± 12™ 50±12 54 + 10 40 ± 15*
Smoking
Potassium concentration
109 (43)+++ 69 (66) 65 (82) 9 (36)*
(mmol/l)
Potassium concentration
3.8 ±0.4 3.8 ± 0.4 3.8 ± 0.5 3.9 ±0.3
<3.5 mmol/I 31 (12) 16 (15) 15 (19) 4(16)
Men 119 (47) 57 (55) 50 (63) 7 (28)
Women 132 (53) 47 (45) 29 (37) 18 (72)
Claudication 14 (6)m 27 (26) 27 (34) 2 (8)*
Congestive heart failure 
Myocardial infarction or
5 (2) 3 (3) 5 (6) 0 (0)
angina pectoris 
Cerebrovascular
13 (5) 7 (7) 9 (11) 1 (4)
accident 7 (3) 3 (3) 3 (4) 0 (0)
Age at onset <20 years 24 (10), 6 (6) 2 (3) 8 (32)*
Abdominal bruits 14 (6)™ 22 (21) 14 (18) 10 (40)*
Malignant hypertension 6 (3) 2(2) 3 (4) 0(0)
Resistance to therapy 115 (46) 57 (55) 54 (67) 11 (44)
Number of patients per group, percentage between brackets (%). *P<0,05, 
versus renal artery stenosis caused by atherosclerosis; ^^<0.001, versus 
renal artery stenosis.
Table 5 shows the results of the analysis of markers for 
RAS in patients who had undergone DSA and for whom 
all of these data were available. The group with RAS was 
divided into two by ascribing the cause of the stenosis to 
atherosclerosis or to FMD. The serum potassium con­
centration was equal in all groups and not correlated with 
RAS. There were significantly more men and smokers in 
the group with RAS caused by atherosclerosis (P< 0.001) 
than there were in the group with RAS caused by FMD. 
Members of the latter group were significantly younger 
(P<0.01). Claudication (P<0.05) was significantly com­
moner among the patients with RAS caused by athero­
sclerosis, whereas female sex (P < 0.001), a low age at onset 
of hypertension CP<0.05) and the presence of an abdominal 
bruit CP<0.05) were associated with RAS caused by FMD.
Discussion
The mean supine baseline blood pressure in the 1047 
hypertensive patients included in this study was 154 + 
24/92 ± 14 mmHg. These values were obtained during a 
standardized procedure using a Dinamap automatic blood 
pressure measuring device. The Dinamap device is based 
on an oscillometric principle that registers blood pressure 
values 3-10 mmHg lower than corresponding sphyg- 
momanometric measurements, both for DBP and for SBP 
[15-17]. Especially in hypertensive ranges the values are 
lower [18]. In our clinic, the Dinamap device measures 
on average DBP 6 + 7 mmHg lower and SBP 11+9 mmHg 
lower than the usual sphygmomanometric method 
(unpublished data). The presented data therefore under­
estimate the actual blood pressures of the patients in this 
study.
Some remarkable differences in blood pressure were pres­
ent among the three groups of patients, i.e. those with 
RAS, those with essential hypertension and those in whom 
angiography had not been performed. Although the most 
important selection criterion for angiography was the blood 
pressure, the subjects with RAS still had a significantly 
higher blood pressure than did those with essential 
hypertension. This emphasizes the importance of blood 
pressure criteria in the selection of patients for angiography. 
The multivariate analysis to investigate the relationship 
of various criteria to the presence of RAS also showed 
blood pressure to be one of the three independent dis­
criminators for the presence of RAS.
Among the patients with SBP >157 mmHg or DBP
> 97 mmHg, on Dinamap recording, the prevalence of
RAS was 30%. SBP > 170 mmHg or DBP > 105 mmHg
measured by sphygmomanometry can be considered equi­
valent to the Dinamap recordings. So, in patients with 
these blood pressure levels after 2 weeks without anti­
hypertensive therapy without a sodium-restricted diet, 
further diagnostic action to detect RAS is warranted, con­
sidering this high prevalence of RAS.
The logistical regression formulae show that the PRA after 
angiotensin converting enzyme inhibition has statistically 
the strongest relationship with the presence of RAS. How­
ever, as has been shown repeatedly, this increase in PRA 
cannot be used as a screening criterion for the presence 
of RAS in the individual patient because the sensitivity 
in this respect is too low [4]. In the present study we used 
different interpretations of the rise in PRA after captopril 
therapy in relation to the presence of RAS. At no point 
could the rise in PRA be used to detect RAS in the 
individual patient because the sensitivities remained low. 
By relying on changes in PRA a great number of stenoses 
would remain undetected. For the same reason none of the 
other patient characteristics could be used as a screening 
criterion for the presence of RAS. Neither did com­
binations of PRA and other studied criteria provide an 
acceptable sensitivity for detecting RAS. Also, the for­
mulae of Müller [14] and our own logistic regressions gave 
no satisfactory results in this large population (Table 4).
The first logistic regression analysis showed that, besides 
PRA, claudication and abdominal bruits are strong pre­
dictors for the presence of RAS. This is not surprising and 
these clinical findings have long been used on a more or 
less intuitive basis as selection criteria for angiography. 
Congestive heart failure, myocardial infarction, cerebro­
vascular accident, malignant hypertension and a low age 
at onset of hypertension also showed a high specificity for 
RAS. However, their prevalence among this group was 
very minor, because of which they can of course not be 
used in the screening for RAS. Therefore, in order to find 
useful screening criteria, a second regression analysis was 
performed in which claudication and abdominal bruits
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were omitted. Besides the already-mentioned PRA, SBP 
turned out to be an independent predictor for RAS. In both 
analyses smoking also turned out to be an independent 
predictor for the presence of RAS. In contrast to abdominal 
bruits and claudication, smoking is very common in the 
hypertensive population leading to a very low specificity 
when it is used as a selection criterion (Table 4), which 
renders smoking unsuitable as a screening selection cri­
terion. So, the blood pressure is the most useful and 
practical clinical clue to the presence of secondary 
hypertension in this study.
The actual prevalence of RAS in the entire hypertensive 
population of this study is at least 10%. Given the pre­
valence described in various studies, it can be assumed 
that the number of patients with a stenosis in the group 
not examined arteriographically could only have been low 
[19,20]. So, we can use the prevalence established in our 
patients as a reference point for further discussion.
What diagnostic tools are presently available to detect 
RAS? Performing arteriography in all of the 1047 patients 
to disclose RAS in 10% is not a realistic option. A cost- 
effective non-invasive screening procedure would be pre- 
ferrable. In this respect non-invasive imaging techniques 
are an option. Doppler ultrasonography performed in the 
entire group would be costly at the gain of discovering
RAS in at most 60% of the patients with proved RAS [5, 
21,22]; in this study, in only 62 of 104 patients. Magnetic 
resonance angiography of the renal arteries shows RAS 
and with application of the latest developments in the 
technique gives very reliable results, but to use it as a 
screening procedure would be very costly [6,23]. Diethyl- 
enetriamine pentaacetic acid or technetium 99m mer- 
captoacetyltriglycine renographies have an overall sensi­
tivity for RAS of approximately 70% [24,25], Thus, screen­
ing of all of the present patients with these renog­
raphies would have resulted in about 70 of the 104 
patients with RAS being detected and a superfluous scan 
performed in 943 patients. An objection against this 
interpretation might be that, with renography, only those 
patients with stenosis are detected that have true reno­
vascular hypertension, defined by cure or improvement 
of blood pressure after removal of the stenosis [26]. How­
ever, multiple large-scale studies have clarified that the 
sensitivity of renography in this respect is even lower than 
that for stenosis as such [3,27].
Newer procedures using acetylsalycilic acid, based on 
the renin- and prostaglandin-dependences of high blood 
pressure in patients with RAS, are bound to suffer from 
the same drawbacks as did previous procedures based on 
the renin-dependence of high blood pressure in the case 
of RAS and can only be judged in more detail by further 
studies [28].
At present, the most adequate practical clinical approach 
to seek RAS in hypertensive patients is the use of blood 
pressure criteria to identify a subgroup with a high pre­
valence of RAS. In such a group it is worthwhile to perform 
renal angiography if there are reasons to suspect secondary 
hypertension. In doing so the clinician has to bear in mind 
that RAS in some patients is not detected. A reasonable 
safety net is introduced if any difficulty in the treatment 
of a hypertensive patient or a decrease in renal function 
during treatment is regarded as a clinical criterion for 
further diagnostic study to detect RAS. The present study 
shows that blood pressure criteria are more adequate means 
to select hypertensive patients for diagnosis of RAS than 
are various sophisticated combinations of clinical and bio­
chemical parameters.
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